Mission

Welcome to Mingowood Pharmacal, where innovation meets botanical therapeutics. We are dedicated to unlocking the full therapeutic potential of botanical compounds, with a particular focus on acidic cannabinoids such as CBDA and THCA.

Our mission centers on our innovative @LDH™ (Layered Double-Hydroxide) formulation technology. This patent-pending method ensures the stability of hemp's key components, the acidic cannabinoids, while enhancing their potency and effectiveness.

Why acidic cannabinoids? These often-overlooked compounds hold immense promise in addressing unmet medical needs. However, their inherent instability presents a significant challenge. Our innovative formulation technology overcomes this hurdle, ensuring the protection and optimal delivery of acidic cannabinoids for enhanced therapeutic outcomes.

By harnessing the power of acidic cannabinoids and leveraging our advanced formulation technology, we aim to redefine the landscape of botanical therapeutics. Join us on our journey to pioneer new frontiers in healthcare, one breakthrough at a time.

To learn more about the importance of botanicals including acidic cannabinoids, click here. If you are interested in learning more about the science behind our formulation technology, click here.